News Medical on MSN
A repurposed drug duo shows powerful synergy against liver fibrosis
A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective ...
The Magnificent Seven represent 34.4% of the S&P 500 as of January 2026, up from 12.5% in 2016. From 2016 through 2025, these seven companies achieved an 870.1% return, outperforming the S&P 500. The ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.
Understand the replacement chain method, a crucial capital budgeting tool for comparing projects with different life spans. Explore how it works, its requirements, and alternatives.
Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback